Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitratt and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (20) , 1308-1312
- https://doi.org/10.1016/0002-9149(90)91318-z
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Long Term Efficacy of a Controlled-Release Formulation of Isosorbide 5-Mononitrate (Imdur®) in Angina Patients Receiving β-BlockersDrugs, 1987
- Experience of Long Term Treatment and Different Dosage Regimens of Isosorbide 5-MononitrateDrugs, 1987
- Mononitrates as Monotherapy in the Prophylactic Treatment of Angina PectorisDrugs, 1987
- Various Administration Forms of Nitrates and Their PossibilitiesDrugs, 1987
- Isosorbide dinitrate and glyceryl trinitrate: Demonstration of cross tolerance in the capacitance vesselsThe American Journal of Cardiology, 1985
- Isosorbide 5-mononitrate kineticsClinical Pharmacology & Therapeutics, 1984
- Pharmacokinetics of intravenous and oral isosorbide-5-mononitrateEuropean Journal of Clinical Pharmacology, 1981
- Effects and pharmacokinetics of isosorbide dinitrate in normal manEuropean Journal of Clinical Pharmacology, 1980
- Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.Circulation, 1977
- Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery diseaseThe American Journal of Medicine, 1977